Healthcare · Biotechnology
Price
$2.35
Market Cap
$166.5M
Employees
4
Beta
-0.18
Avg Volume
30,872
CEO
Ethan Shen
Business Description
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Business History
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-19.58
Stock Price: $2.35
EPS (Diluted): -0.12
EPS (Diluted): -0.12
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
-284.80
Stock Price: $2.35
Total Equity: -$2.86M
Shares: 66,719,177
Total Equity: -$2.86M
Shares: 66,719,177
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-99.63
Market Cap: $166.45M
Total Debt: $0.00
Cash: $6.01M
EBITDA: -$8.10M
Total Debt: $0.00
Cash: $6.01M
EBITDA: -$8.10M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$807.3M
Market Cap: $166.45M
Total Debt: $0.00
Cash: $6.01M
Total Debt: $0.00
Cash: $6.01M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
1,362.74
Stock Price: $2.35
Revenue: $596,817
Shares: 66,719,177
Revenue: $596,817
Shares: 66,719,177
EV/Sales (Total value vs revenue — works when P/E can't)
API1,352.69
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
-7.1%
Gross Profit: -$42,149
Revenue: $596,817
Revenue: $596,817
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-883.3%
Operating Income: -$5.27M
Revenue: $596,817
Revenue: $596,817
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-1,392.6%
Net Income: -$8.31M
Revenue: $596,817
Revenue: $596,817
ROE (Profit from shareholder equity)
CALCNet Income / Total Equity
291.0%
Net Income: -$8.31M
Total Equity: -$2.86M
Total Equity: -$2.86M
ROIC (Profit from all invested capital)
CALCNOPAT / Invested Capital
59.5%
Operating Income: -$5.27M
Tax Rate: 0.0%
Equity: -$2.86M
Total Debt: $0.00
Cash: $6.01M
Tax Rate: 0.0%
Equity: -$2.86M
Total Debt: $0.00
Cash: $6.01M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
5.88
Current Assets: $9.67M
Current Liabilities: $1.64M
Current Liabilities: $1.64M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: -$2.86M
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: -$2.86M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$0.01
Revenue: $596,817
Shares: 66,719,177
Shares: 66,719,177
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$-0.04
Total Equity: -$2.86M
Shares: 66,719,177
Shares: 66,719,177
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.12
Operating CF: -$6.60M
CapEx: -$1.44M
Shares: 66,719,177
CapEx: -$1.44M
Shares: 66,719,177
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $2.35
Stock Price: $2.35
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$8.31M
Net Income: -$8.31M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares YDES against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 27, 2026 1:45am (8h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $350,131 | $510,360 | $596,817 |
| Cost of Revenue | $0 | $0 | $196,686 | $355,004 | $638,967 |
| Gross Profit | $0 | $0 | $153,445 | $155,356 | $-42,149 |
| Operating Expenses | $1.7M | $2.3M | $163,292 | $1.6M | $5.2M |
| Operating Income | -$1.7M | -$2.3M | $-9,847 | -$1.5M | -$5.3M |
| Net Income | $8.7M | $3.8M | $13,560 | -$1.4M | -$8.3M |
| EBITDA | $8.7M | $3.8M | $22,246 | -$1.3M | -$8.1M |
| EPS | $0.59 | $0.41 | $0.00 | $-0.56 | $-0.12 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 27, 2026 1:45am (8h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5,403 | $14,129 | $87,098 | $3.1M | $6.0M |
| Total Current Assets | $129,560 | $202,705 | $271,724 | $3.5M | $9.7M |
| Total Assets | $118.1M | $17.9M | $321,212 | $6.9M | $13.8M |
| Current Liabilities | $2.0M | $5.6M | $298,218 | $263,060 | $1.6M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $9.1M | $6.7M | $298,218 | $273,980 | $16.6M |
| Total Equity | $109.0M | $11.2M | $22,994 | $6.6M | -$2.9M |
| Retained Earnings | -$6.5M | -$6.5M | $-515,484 | -$1.9M | -$10.2M |
Cash Flow (Annual)
Last updated: Jun 27, 2026 1:45am (8h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-688,415 | -$3.0M | $-55,657 | -$1.8M | -$6.6M |
| Capital Expenditure | $-5 | $0 | $-290 | -$2.9M | -$1.4M |
| Free Cash Flow | $-688,420 | -$3.0M | $-55,947 | -$4.7M | -$8.0M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | -$101.5M | $0 | $0 | $0 |
| Net Change in Cash | $-688,415 | $8,726 | $56,956 | $3.0M | $2.9M |
Growth Trends (YoY %)
Last updated: Jun 27, 2026 1:45am (8h ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | — | +45.8% | +16.9% |
| Gross Profit Growth | — | — | +1.2% | -127.1% |
| Operating Income Growth | -34.9% | +99.6% | -14,746.5% | -260.6% |
| Net Income Growth | -56.5% | -99.6% | -10,509.7% | -488.8% |
| EBITDA Growth | -56.5% | -99.4% | -5,858.2% | -532.6% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for YDES — it's generated by the pipeline (
market-narrative step).
No community reviews yet for YDES.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30